174 related articles for article (PubMed ID: 37745721)
1. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
[TBL] [Abstract][Full Text] [Related]
2. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
4. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
[TBL] [Abstract][Full Text] [Related]
6. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
7. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
8. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
[TBL] [Abstract][Full Text] [Related]
9. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
11. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound and clinical factors predicting central lymph node metastases in patients with unilateral multifocal papillary thyroid carcinoma.
Liang Z; Zhang J; Chen L; Liu J; Wang F; Shao Y; Sun X; Chen L
Asia Pac J Clin Oncol; 2024 Apr; ():. PubMed ID: 38659209
[TBL] [Abstract][Full Text] [Related]
13. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
[TBL] [Abstract][Full Text] [Related]
14. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
16. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic implications of multifocal papillary thyroid carcinoma on poor prognostic outcomes: a propensity score matching analysis].
Qiu B; Zhao B; Wang T; Yin DT
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(30):2332-2336. PubMed ID: 31434412
[No Abstract] [Full Text] [Related]
19. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
20. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]